Detecting hidden small airway issues in cystic fibrosis patients
Official title: The Measurement and Analysis of Maximal Expiratory Flow Volume Loops at Low Lung Volumes in Children With Cystic Fibrosis and Normal Routine Lung Function.
Run by Gelb, Arthur F., M.D. · NCT03839992 · Data updated 2026-11-12
This study is trying to find hidden breathing problems in children and adults with cystic fibrosis who seem healthy on standard lung tests by looking at their lung scans and airflow patterns.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 5 Years to 40 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Gelb, Arthur F., M.D. Indiv |
| Locations | 2 sites (Lakewood, California and 1 other locations) |
| Status | Recruiting |
| Started | April 25, 2018 |
| Main results expected | April 25, 2027 |
| Study ends | November 25, 2027 |
| Registry record updated | October 26, 2023 |
| Trial ID | NCT03839992 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are heterozygous or homozygous cystic fibrosis patients with normal pre bronchodilator spirometry results.
✕Probably not a fit
Patients with abnormal routine pre bronchodilator spirometry results will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify unsuspected small airways obstruction in children and adults with cystic fibrosis who have normal routine spirometry results. It utilizes retrospective analysis based on previous research that demonstrated the ability to detect airflow limitations at low lung volumes, despite normal FEV1 and FVC values. The study focuses on the correlation between abnormal expiratory airflow and the presence of bronchiectasis as shown in lung CT scans. By analyzing these factors, the researchers hope to improve the understanding of lung function in cystic fibrosis patients.
Why it matters
Potential benefit: If successful, this study could lead to earlier detection and better management of lung complications in cystic fibrosis patients.
How similar studies have gone: Previous studies have shown success in detecting small airway obstruction using similar methodologies, indicating a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Heterozygote or homozygote patients with cystic fibrosis with normal routine pre bronchodilator spirometry including normal FEV1(L), FVC(L) and FEV1/FVC%. Exclusion Criteria:Heterozygote or homozygote patients with cystic fibrosis with ABNORMAL routine pre bronchodilator spirometry \-
Where it's running
-
Arthur F Gelb MD
Lakewood, California, United States Recruiting -
Miller Children's Hospital and Long Beach Medical Center
Long Beach, California, United States Recruiting
Study contacts
- Principal investigator: Arthur Gelb, MD — University of California, Los Angeles
- Study coordinator: Arthur F Gelb, MD
- Email: afgelb@msn.com
- Phone: 562-565-5333
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Physical function and symptoms in children with cystic fibrosis
This project will compare breathing difficulty, exercise capacity, muscle strength, bladder control, and quality of life in children aged 6–18 with cystic fibrosis versus healthy peers to see where support is needed.
-
Measuring reflux symptoms in children with cystic fibrosis after stopping GERD treatment
This study is trying to see how stopping GERD treatment affects reflux symptoms in children with cystic fibrosis aged 6-17.
-
Investigating the impact of probiotics on gut health and quality of life in children with cystic fibrosis
This study is testing if giving probiotics can improve gut health and quality of life for children with cystic fibrosis.
-
Impact of CFTR Modulators on Sinus Health in Young Children with Cystic Fibrosis
This study is testing if a new treatment for cystic fibrosis can improve sinus health and smell in young children aged 2-8.
-
Using 19F MRI to study lung ventilation in children with cystic fibrosis
This study is testing a new MRI method to see how well children with mild cystic fibrosis breathe compared to healthy kids their age.
-
Inhaled CFTR mRNA for cystic fibrosis in Chinese patients aged 12 and older
This trial tests inhaled BMD003, a CFTR mRNA therapy, to see if it's safe and shows early signs of benefit in Chinese people 12 years and up with cystic fibrosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.